A detailed history of Lynx Investment Advisory transactions in Sanofi stock. As of the latest transaction made, Lynx Investment Advisory holds 109 shares of SNY stock, worth $5,763. This represents 0.0% of its overall portfolio holdings.

Number of Shares
109
Holding current value
$5,763
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$45.39 - $50.36 $4,947 - $5,489
109 New
109 $5.29 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $133B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Lynx Investment Advisory Portfolio

Follow Lynx Investment Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynx Investment Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Lynx Investment Advisory with notifications on news.